Letter from the Chair
Greetings Members of the Epidemiology Section
After I received my epidemiology and biostatistics masters degree, a fierce-looking senior professor of medicine and attending physician at the medical school where I was interviewing asked me to define “epidemiology.” Flustered and caught off-guard, I stuttered an answer, to which he responded, semi-smiling, with the most succinct and complete definition I had heard up to that time. It has stuck with me ever since: “Epidemiology is the study of diseases (and disease-related conditions) with regards to person, place and time.”
Despite my perceptions that I had blown the interview by not showing off my recent training to the fullest, I was admitted to medical school. And that “fierce” professor turned out to be a kind and caring person interested in what his students knew and would do to prevent diseases and treat the ill. I realized more than ever during this training that epidemiology was at the heart of population medicine, providing objective evidence overlooked when clinicians only rely on clinical case-by-case experiences, and that the separation of epidemiology (and public health) from the clinical sciences was an artificial, relatively recent phenomenon.
Nonetheless, last year, NIH failed to acknowledge the importance of epidemiologic perspectives when appointing the task force for external review of NIH peer review processes. This action concerned the over 14 epidemiologic societies represented in the Congress of Epidemiology 2006 (and now 2010) Joint Policy Committee, in which APHA Epidemiology Section leadership plays an active role. The Congress JPC wrote NIH leadership about those concerns.
In their letter back, NIH characterized epidemiology as just “one of the specialties” rather than as a core tool for understanding clinical findings in larger population contexts. NIH also did not acknowledge that epidemiology has successfully been used to translate clinical breakthroughs to appropriate populations and then to monitor both use of clinical interventions as well as the benefits and harms of such innovations—some of which may not be anticipated from tightly controlled, randomized trials of select patients.
The JPC is now exploring ways that our societies might more effectively discuss the contributions of epidemiology to research and public health practice and address how epidemiologic expertise would be helpful in NIH’s effort, something NIH has apparently overlooked.
This challenge is just one of many interesting challenges that lie ahead for our Section in the coming year. I look forward to serving as the Chair of the Epidemiology Section, and I thank all of you for your involvement in our organization and in the many worthwhile activities we take on.
Person, place and time—now and in the past— are also relevant themes for the APHA Epidemiology Leadership Team and Section activities. This year will be an exciting one! Now is the time for your involvement as a member!
Dr. Jim Gaudino
Return to Top
Looking Back: Person, Place, and Time in the 2007 Epi. Section
Looking Back: Person, Place, and Time in the 2007 Epi. Section
It is with all humility and honor that I take on the role of Chair of the Epidemiology Section—a section some 3000 members strong, and I thank once again Dr. Stan Weiss, now Immediate Past Chair; Dr. Linda Hazlett, Immediate Past Program Chair, Dr. Howell Sasser, former Section Secretary and Newsletter Editor and Annual Meeting Social Coordinator; Dr. Steve Godin, Section Webmaster; Dr. Robin Taylor Wilson, Immediate Past Governing Council Whip, and the other members of the leadership team from these past years for their extraordinary years of service. Please join me in thanking these colleagues for all their hard work! I will introduce some of our current Section leaders below.
Let me review some of our Section’s work in 2007, starting with highlights from November 2007’s Annual Meeting.
2007 Section-hosted Sessions
The Section hosted 45 contributed and invited sessions, including 12 poster sessions, the Section Awards Ceremony Session, a very well attended student-mentor Careers in Epidemiology Session, and a special session discussing the tensions between human subjects protection internal review requirements for research and the application of public health practice and program evaluation exclusions as non-research by public health authorities. Another highlight was a special session engaging Congressional legislative staffers and epidemiologists in discussing how epidemiologic data are really used and needed by legislators and the pitfalls often made by researchers when communicating research findings during legislative or policy development processes. There were high quality scientific presentations on a full array of public health topics.
2007 Section-sponsored Awards
A packed agenda in the Section Awards Session included senior career awards for and lectures by three distinguished colleagues as well as other awards.
John Snow Award:
Dr. David Schottenfeld, Professor Emeritus at the University of Michigan, received the John Snow Award for his seminal work on cancer epidemiology and translation of research to practice. Dr. Phil Mackie from the John Snow Society and Royal Institute of Public Health in London, which officially sanctions the Section Award, joined us to bestow the honors.
Abraham Lilienfeld Award:
Dr. Michelle Williams, Professor at the University of Washington (UW), received the Abraham Lilienfeld Award for teaching epidemiology and mentoring domestic and international students and junior colleagues as the founder and director of the Multidisciplinary International Research Training (MIRT) Program, and in her work at UW.
Wade Hampton Frost Lecture:
Presenting the Wade Hampton Frost Lecture this year was Dr. Gary Wormser, Professor at the New York University Medical Center. Dr. Wormser discussed his early, cutting-edge work identifying, studying and treating patients with HIV/AIDS during the first wave of the US epidemic in the 1980s. He also discussed his ongoing work on Lyme Disease, a consequence of Borrelia burgdorferi infection, and on current conundrums regarding a less well described but suspected Borrelian diseases in the US. Reflecting on the art and science of epidemiologic endeavors, he challenged us to apply Donald Rumsfeld’s construct of “known knowns, unknown knowns, known unknowns and unknown unknowns” in epidemiologic investigations—there is so much more to learn.
Public Health Practice Award:
In this third year of the Epidemiology Section’s Public Health Practice Award, we honored the New York City Dept. of Health and Mental Hygiene Bureau of Tobacco Control, for outstanding work having a measurable impact with their smoking cessation program. For this next year’s awards, please consider nominating any colleagues within ten years of their training or any organizations or agencies who through their efforts have a measurable, positive impact on a public health condition or better address public health issues.
Last but not least, we recognized with cash stipends the stellar scientific work of three students and their colleagues for their outstanding abstracts and papers. We’re looking forward to another set of high quality student abstracts to review again for this year! Looking to the future, we also honored the impressive work of several high school students as Young Epidemiology Scholar (YES) Finalists this last year. We are honored that Dr. Pamela Russo, Senior Program Officer representing the Robert Wood Johnson Foundation and her colleagues from the College Board, YES sponsors, joined us in recognizing and honoring the scientific work of these talented students, who received substantive scholarship awards to continue their scientific pursuits when they advance to university studies. To read about the YES program, please go to the YES website: www.collegeboard.com/yes.
Please see below how you may contribute to next year’s successful recognition of the valuable work of our senior career, new career, and student colleagues in October.
2007 Section Policy Activities
Last year was another busy year for the APHA Governing Councilors with policy review activities and APHA leadership elections. As always, Epi Section Governing councilors were actively engaged in APHA policy resolution reviews and, also, several leaders served on the APHA Joint Policy Committee (JPC) and Science Board. New policies ultimately passed by the Governing Council as a result of these efforts will soon be posted on the APHA website.
In fact, our section co-authored one resolution to highlight increasing problems that public health agencies and school health programs are encountering with the older Federal law governing school privacy, called Family Education Rights Privacy Act (FERPA) passed 30 plus years before the HIPAA law governing patient privacy. The forthcoming APHA policy, called Promoting School Information Sharing for Public Health Purposes, describes FEPRA and points out that, unlike HIPAA, FEERPA has no exception allowing access to school records, including school health records for public health purposes. The policy also explains increasing difficulties that public health agencies and school health programs are having in obtaining needed data in the face of new public health challenges that need earlier life interventions, e.g., growing obesity and rise of Type II diabetes among school children.
Section leaders also participated in and debated the proposal to increase APHA dues and add the new multiple section membership option for additional fees. When these new fees were approved by the APHA Governing Council (GC), section leaders joined with several other sections in proposing that APHA staff provide ongoing data reports on the impacts of the new fees. This later proposal also was approved by the GC and hopefully will provide APHA with needed information about how dues changes impact the membership of the organization.
2007 Section Social Event
Finally, the Section Social Tuesday night was a smash hit event, thanks to Dr. Howell Sasser and several other leaders, drawing over 100 members, well over our estimate. Student and career section members and their invited guests enjoyed tasty Spanish tapas treats as they networked! One professor from the University of Florida brought several of his students with him to the event, making sure they were well fed, celebrated their successes as student presenters, and met key contacts for future opportunities. Now that’s a faculty mentor! We even made contacts with colleagues living in San Diego willing to help plan our next social! So, please add Tuesday night during APHA in San Diego to your calendars for another chance for students, mentors and colleagues to met and greet each other! If you would also like to help plan this fun event, please contact me.
Dr. Jim Gaudino
Return to Top
Looking Forward: Person, Place, and Time in the 2008 Epi. Section
The 136th APHA annual conference will be held in October 2008 in San Diego, CA. This year’s timely APHA conference theme is “Public Health Without Borders.”
2008 Section-hosted Sessions
The Program Committee of the Epi Section is gearing up to host a great array of contributed and invited sessions. The Section received approximately 400 contributed abstracts by the extended February 15th deadline! Thank you for those submissions. Proposals for invited sessions are due in the next few weeks. Please check the APHA 2008 annual meeting Epidemiology Section “Call for Abstracts” webpage for more information. For those of you with new, pending work, please keep your eyes out for a call for late-breaking abstracts some time in late summer or early fall!
2008 Section Leadership: Welcome to All!
While a few Section leaders have retired from leadership this year, new leaders, including six student leaders, are joining us, and experienced colleagues continue in different positions on the 30-plus member Epi Section Leadership team. We are excited that several of our student leaders also serve in key positions with the APHA Student Assembly or serve as liaisons with other sections, caucuses or SPIGs.
Please welcome to the team Dr. Claudia Kozinetz, our new Chair-Elect; Dr. Aaron Mendelsohn, our Program Chair; Mr. Oscar Alleyne, our Section Secretary and Newsletter Editor; Dr. Steve Godin, Section Webmaster; Dr. Howell Sasser, our Governing Council Whip; and Dr. Sonja Hutchins, Chair of a new Policy Committee to better coordinate Section policy and advocacy activities.
A quick plug here: if you are interested in finding out how to get more involved or in joining the Section leadership group, please contact Dr. Stan Weiss, Epi Section leadership nominations chair, or any one of the leadership team during the year. Besides working with a great group of leaders, you can make a difference. Nominations to run for leadership positions (section councilor, section governing councilor or other positions as available) can be made up to late February to early March every year, and one may nominate oneself.
2008 Section Involvement on APHA Boards and Committees
The Section is also very active on APHA Boards & Committees and those serving from the Epidemiology Section include:
--APHA Science Board (SB): Dr. Stan Weiss, new Vice Chair of the SB who also recently completed serving as a member of the Joint Policy Committee (JPC) and Dr. Elizabeth Bancroft, SB member and Section Governing Councilor.
--APHA Nominations Committee: Dr. Howell Sasser.
(Yes, this is the committee that nominates President-Elect, Executive Board, and other candidates for APHA’s executive-level volunteer offices. Please contact Dr. Sasser should you or colleagues have any suggestions for nominations or wish to nominate a deserving candidate by early March 2008 for this year or March 2009 for the following year.)
--APHA Action Board: Dr. Ruth Allen
--Education Board: Dr. John Neuberger, now serving as the newly appointed Vice Chair.
--Membership Committee: Dr. Toni Alterman
--Section liaisons to the Congress of Epidemiology 2011 Planning Committee and Leadership Team: Dr. Claudia Kozinez, Dr. John Vena, Dr. Stan Weiss and Dr. Jim Gaudino.
--Section liaisons to the Congress of Epidemiology Joint Policy Committee of the Congress of Epidemiology Societies: Dr. Stan Weiss, Dr. Sonja Hutchins, Dr. Howell Sasser, and Dr. Jim Gaudino.
The Section Awards Committee is gearing up and we need your suggestions or nominations as mentioned above. Chairing three groups within the Awards Committee that work on the different award are: Dr. Claudia Kozinetz for the three lifetime achievement career awards, Dr. Kris Fennie for the Public Health Practice Award(s), and Dr. Aaron Mendelsohn for the APHA Epidemiology Section Student Paper Awards. Please contact each of these leaders with your suggestions for nominations, willingness to serve on one of these groups, and/or questions.
2008 Section Policy Activities
Reviewing policy proposals: Soon a new cycle of proposed APHA policy resolutions and statements will be submitted and Section Governing Councilors (GC) will be reviewing the proposals in March or April once they are posted on the Legislative/Governance pages of the “Members Only” (APHA membership needed to log in) area on the APHA website. We are already involved with discussions about several hot button policy proposals. As always, there will be proposals on topics that require us to reach out for the expertise of our membership. We would certainly welcome those of you, including students, interested in being expert reviewers!
Student Shadows: Our GC will be looking for interested students to be “governing councilor student shadows” to assist GC members throughout the year with policy reviews, including the open hearings on policy proposals at the annual meeting. What better way to get involved than to help APHA and the Epi Section develop evidenced-based policies. Please contact Dr. Howell Sasser, GC Whip, for more information on policy reviews and the student GC shadow positions.
Section Policy Committee: The newly formed Section Policy Committee is just organizing to better facilitate section activities on policy and advocacy activities, including identifying policy issues that the Epi Section could author or co-author. We would welcome your ideas and input on how the Epi Section could be more effective on policy development and advocacy work. Please contact Dr. Sonja Hutchins with any ideas you have or if you would like to volunteer!
2008 Newsletter Contributions
We are looking for your ideas and contributions for our quarterly newsletter. If you have an important announcement or would like to briefly highlight some important epidemiologic findings, please contact Mr. Oscar Alleyne.
Looking forward to a great year for the APHA Epidemiology Section and for your involvement!
The persons are our section members, the place is wherever our members are, especially in San Diego this year in October, and the time to get involved is now!
Dr. Jim Gaudino, Chair
American Public Health Association Epidemiology Section
Contact Information for (or check our website):
Mr. E. Oscar Alleyne
Dr. Kristopher P. Fennie
Dr. Sonja S. Hutchins
Dr. Claudia A Kozinetz
Dr. Aaron Mendelsohn
Dr. Howell C. Sasser
Dr. Stanley H. Weiss
email@example.com and firstname.lastname@example.org
For more information about the section, please visit the APHA Epidemiology Section web page at:
Section newsletters, from Fall 2003 on, are archived & accessible by members at:
Return to Top
Section Leader Testifies on the Hill
Testimony of Elizabeth A Bancroft, MD to the House Committee on Oversight and Government Reform on "Drug Resistant Infections in the Community: Consequences for Public Health"
Wednesday, November 7, 2007
Good Morning. I want to thank the Committee for the opportunity to talk to you about MRSA and antibiotic resistance in the community.
According to a CDC study published October 17, 2997, in the Journal of the American Medical Association, the rate of invasive MRSA, meaning MRSA that has gotten to the blood, spinal fluid or other deep body sites, was greater than the combined rate of invasive disease caused by the most significant bacterial infections that we commonly follow in public health (including group A strep [the so-called "flesh eating disease"], and pneumococcal disease, another important antibiotic resistant infection). Furthermore, the number of deaths associated with invasive MRSA, approximately 18,000, was estimated to exceed the number of deaths due to HIV/AIDS. On the other hand, the estimated number of deaths due to MRSA is only half of the estimated number of deaths due to influenza in the United States each year (36,000 deaths) which is, or should be, a largely preventable infection.
In the same way that there are 2 main strains of politicians in Washington, Republicans and Democrats, it is important to recognize hat there are 2 main "strains" of MRSA: healthcare associated MRSA and community associated MRSA. Healthcare associated MRSA occurs in people who have had significant exposure to healthcare (hospitalization, surgery, dialysis, nursing home) in the year prior to their infection. It tends to affect the elderly and is associated with a relatively high rate of death. In contrast, community MRSA occurs in those who have not had any significant exposure to healthcare in the year prior to their infection. It comprises only 14% of all invasive MRSA infections, is sensitive to many oral antibiotics, and results in many fewer deaths than healthcare MRSA. From laboratory studies, it appears that the strains of healthcare MRSA and community MRSA arose separately and that community MRSA is not simply a rogue hospital strain.
The media have commonly confused the 2 strains of MRSA, conferring the attributes of healthcare MRSA (invasive disease and high rate of death) to that of community MRSA. Much of the recent media has focused on deaths due to MRSA in school children. However, according to the CDC study, the lowest rate of invasive MRSA occurs in school age children 2-17 years and the death rate in children with community MRSA was estimated to be 0, though obviously there can be exceptions. Only 6% of community MRSA cases result in invasive disease. The vast majority of community MRSA cases are skin and soft tissue infections. Many of these infections can be cured by a simple drainage procedure and may not even require antibiotics.
Despite the relatively low burden of invasive disease caused by community MRSA, outbreaks of skin infections due to this organism tax the public health system and the facilities in which they occur. For example, just one case of an MRSA skin infection in a school recently resulted in the closure of a school system for environmental decontamination. This causes disruption to the school system, students, and their parents, and is not consistent with any public health recommendations.
In Los Angeles County, we have been addressing community MRSA since 2002 when we first investigated outbreaks of this organism in diverse settings including the Jail, men who have sex with men, and an athletic team. We have developed extensive health education for consumers and healthcare workers about community associated MRSA along with graphic pictures illustrating the range of infections caused by this bug.
Separately we have had to address concerns by fire fighters, the police, paramedics, social workers, and sheriff’s deputies who are worried about getting this infection on the job. In conjunction with the CDC, we developed guidelines for the prevention of Staph in non-healthcare settings and have disseminated those to homeless shelters, schools, and commercial gyms. Though the media concentrates on children with MRSA, our largest recurring outbreak has been in the Los Angeles County Jail where more than 3,000 cases of MRSA skin infections have been diagnosed in each of the past several years. The County has spent millions of dollars trying to reduce the spread of MRSA in the Jail and only now, after 5 years, are we seeing a leveling off of infections. However, with the constant re-introduction of this organism into the Jail from the community and the close, crowded living conditions inherent in correctional facilities, I don’t think that we will be able to eliminate these infections. Controlling community MRSA, or any outbreak of skin infections, is not rocket science.
We know the basics: handwashing, maintaining good hygiene, limiting sharing of personal items, and keeping draining infections covered with a clean, dry bandage. There are still some questions as to the role of the environment, if and when to perform surveillance for MRSA, and how best to control outbreaks with minimal interventions and maximal impact. We want to work with CDC and other public health agencies to address these questions.
Finally, healthcare acquired infections are conservatively estimated to cause 100,000 deaths a year in the United States. MRSA may only cause ~10% of hospital acquired infections so controlling MRSA in hospitals must be seen as a part of a larger effort to control all healthcare acquired infections. Controlling healthcare acquired infections can be accomplished with evidence based interventions including handwashing, isolating patients, and using vigorous infection control techniques when performing invasive medical procedures. These techniques are well known but they are imperfectly and intermittently practiced. We lack enforcement agencies that will regularly inspect hospitals and hold them to infection control standards. In public health, we routinely inspect restaurants more often than we inspect hospitals. Simply put, we need to same resources that we use for inspecting restaurants to inspect hospitals. We need to hold hospitals to the same standards as we hold McDonalds. The good news is that all the interventions used to control MRSA, in the community and in healthcare, will also control the spread of other infections.
Return to Top
Study finds 37.4% HIV seroprevalence among street youth in St. Petersburg, Russia
The study conducted by the U.S. Centers for Disease Control and Prevention, Doctors of the World–USA, and the St. Petersburg City AIDS Center reported that nearly 4 of every 10 street youth (defined as young people living part or full time on the street, or not attending school) surveyed in St. Petersburg, Russia, are HIV-positive, placing this population among the groups most at-risk for HIV around the world.
The study, conducted in April and May 2006 in St. Petersburg, Russia, involved random selection of 22 out of 41 locations where street youth gathered, counseling and rapid HIV testing for all consenting 15 to 19-year-old male and female street youth at these sites, and an interviewer-administered survey. HIV prevalence among the 313 surveyed youth was found to be 37.4%. The HIV rate exceeded 60% among street youth who were orphans and was nearly 80% among those who used injection drugs—among the highest reported HIV rates in the world. The findings also demonstrated that HIV-infected street youth in Russia have a low likelihood of abstaining from sex, are unlikely to have only one sex partner, and are not likely to use condoms consistently.
The study highlights the fact that the HIV epidemic in Russia, the largest in all Eastern Europe and Central Asia, is most concentrated among youth; that Russia’s 1 to 3 million street and out-of-school youth are at particularly high risk for HIV; and that health officials need to address the social, behavioral, and medical issues that are adversely affecting the health and survival of this high-risk population.
Source: Kissin D, Zapata L, Yorick R, Vinogradova E, Volkova G, Cherkassova E, Lynch A, Leigh J, Jamieson D, Marchbanks P, Hillis S. HIV seroprevalence in street youth, St. Petersburg, Russia AIDS. 2007 Nov;21(17):2333-40.
Submitted by Dmitry Kissin (e-mail: email@example.com)
Return to Top
National Public Health Week 2008
Celebrate National Public Health Week 2008
Climate Change: Our Health in the Balance
The health effects of climate change will take center stage during National Public Health Week, April 7-13, 2008. As part of the weeklong observance, themed "Climate Change: Our Health in the Balance," APHA will lead the charge in helping people, communities, and families recognize that adapting to climate change and mitigating its impact is critical not just for the health of our planet, but for the health of the people in our nation and around the world.
Changes in our climate are causing more severe weather events. Extreme weather conditions such as, heat waves, high winds, snowstorms, floods and hurricanes have the potential to dramatically affect the health and safety of both individuals and our communities. Changing ecosystems allow for emerging or re-emerging infectious diseases such as, dengue or malaria which are changing the spectrum of disease risks affecting populations. In poorer parts of the world, drought and floods often force people to move away from lands no longer producing enough food often resulting in hunger and malnutrition. Moreover, contaminated drinking water can result in outbreaks of diarrheal diseases leading to dehydration or death.
Few Americans will ever see the melting Greenland ice cap up close, or interact with an arctic polar bear facing extinction as its habitat melts. But local public health professionals around the country increasingly will be dealing with the impacts of climate change on the ground, every day. Join APHA as we work to create a healthier planet.
Visit the official National Public Health Week website at
to check out the climate change blog and brochure, sign up to be a National Public health Week partner, or add your week's event to the national calendar. For more information about National Public Health Week, contact
Return to Top
Fellowships and Vacancy Announcements
Visit the Epidemiology Fellowship Board for fellowship and internship opportunities
Visit the Epidemiology Job Board for academia, non-profit, and other research positions
University of Maryland, College Park School of Public Health, Department of Epidemiology and Biostatistics Position Vacancy: Assistant Professor (Tenure Track) in Epidemiology
The Department of Epidemiology and Biostatistics is seeking a tenure-track position in Epidemiology in our new School of Public Health. The Department’s mission is to improve health and reduce health disparities in local communities, the state of Maryland, and the nation. We accomplish this by using established epidemiological and quantitative methods, as well as developing new scientifically grounded approaches, that are applied predominately to identifying determinants of health and discovering and evaluating primary and secondary prevention strategies for chronic diseases. We offer the MPH degree in the concentrations of Epidemiology and Biostatistics and also a PhD in Epidemiology. The position represents a unique opportunity to join a growing department and make important contributions to an exciting research agenda and graduate student training program.
Candidates must possess a doctorate in Epidemiology from an accredited School of Public Health. A record of professional publications and activities in epidemiology-related work that supports a tenure-track position at the Assistant Professor rank is required. Candidates must also demonstrate potential for developing a strong program of externally funded research. Research interests and expertise should align with those of the department and focus on population-based studies. Research areas of particular interest to the department include, but are not limited to, social and behavioral factors in health and epidemiology of cardiovascular disease, cancer, diabetes, and obesity. Special emphasis on health disparities, disease prevention, nutrition and health promotion is desirable. Previous teaching experience, along with interests and ability to teach intermediate or advanced graduate level epidemiologic methods courses, is preferred. Demonstration of collaborative work is highly desirable.
Successful candidates are expected to be actively involved in extramural-funded, multidisciplinary research (or demonstrate the potential for such activity), teach intermediate or advanced graduate level epidemiology courses, mentor graduate students, and engage in service. Effective interpersonal, communication, and collaborative skills are essential.
SALARY and APPOINTMENT DATE
This is a twelve-month tenure-track appointment with up to 75% state funding. Salary is competitive and commensurate with qualifications and experience. Appointments may begin August 2008 or a mutually agreed upon date.
For full consideration, applicants should submit a letter of application clearly indicating how they meet the qualifications described above, current research interests and future research plans, a current curriculum vitae, and contact information for three references. Review of applications will begin November 30, 2007 and continue until the position is filled. Application materials should be sent electronically to: Tina Madison at firstname.lastname@example.org
The University of Maryland is a Research Extensive University. College Park is the flagship campus of the University of Maryland System with over 2,500 faculty and 25,000 undergraduate and 10,000 graduate students. The University is located 8 miles from Washington D.C. For further information on the Department of Epidemiology and Biostatistics, please visit our Web Site: http://www.hhp.umd.edu/EPIB.
The University of Maryland is an equal opportunity and affirmative action employer dedicated to increasing the diversity of its faculty and administrators. We encourage applications from qualified individuals with varied experiences, perspectives and backgrounds. Applications from minority and women candidates are strongly encouraged.
Return to Top
Epidemiology Newsletter Archives